AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 107 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,594,122 | -37.0% | 563,342 | +9.4% | 0.01% | -28.6% |
| Q2 2023 | $5,709,365 | +13.2% | 514,821 | +56.7% | 0.01% | 0.0% |
| Q1 2023 | $5,042,291 | +112.6% | 328,488 | +207.3% | 0.01% | +100.0% |
| Q4 2022 | $2,372,111 | +612.3% | 106,900 | +423.8% | 0.01% | +600.0% |
| Q3 2022 | $333,000 | -2.6% | 20,409 | +46.8% | 0.00% | 0.0% |
| Q3 2021 | $342,000 | – | 13,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
| COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
| Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
| 5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
| RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
| RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
| COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
| Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
| Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
| Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |